In 56-week studies, patients taking Contrave alongside diet and exercise lost an average of 5-9% of their body weight, compared to 1-5% with a placebo, meaning the medication contributed roughly 4-5 percentage points of additional weight loss.4,5 About 46% of patients on Contrave achieved at least 5% weight loss by week 16
198,199 Several GLP-1 receptor agonists have received FDA approval for the treatment of type 2 diabetes and obesity, with some being further indicated for cardiovascular protection
Among these factors, iron availability is likely the most direct determinant
M.VesicK.PetrovicI.JovanovicI
These injectable weight loss treatments are a blend of vitamins, minerals, and nutrients but can have many side effects
Do I need a nutritional plan to protect muscle mass